Clinical guidance for the use of dupilumab in eosinophilic esophagitis: A yardstick.
Ann Allergy Asthma Immunol
; 130(3): 371-378, 2023 03.
Article
em En
| MEDLINE
| ID: mdl-36521784
ABSTRACT
The Joint Task Force for the American Academy of Allergy Asthma Immunology and American College of Allergy Asthma Immunology and the American Gastroenterology Association recently published guidelines for the management of eosinophilic esophagitis (EoE). Because the guideline was published, dupilumab became the first and only medication to gain regulatory approval for the treatment of EoE. This expert opinion document provides a framework for how the clinician can consider using dupilumab in the treatment strategy for patients with EoE.
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Asma
/
Esofagite Eosinofílica
Tipo de estudo:
Guideline
Limite:
Humans
País/Região como assunto:
America do norte
Idioma:
En
Ano de publicação:
2023
Tipo de documento:
Article